Azithromycin
No
No
Dear Healthcare Professional Letters
Standard Drug List
Active ingredient: Azithromycin
General information
Subsidy Information and Financing Scheme
[SDL] Azithromycin Extended-Release Oral Suspension 2 g
[SDL] Azithromycin Injection 500 mg
[SDL] Azithromycin Oral Suspension 200 mg/5 mL
[SDL] Azithromycin Tablet 250 mg
Drug Guidance for Subsidy
Not Applicable
Post Marketing Information
General Availability in Public Healthcare Institution
Note:
General availability information reflected is based on the Public Healthcare Institutions’ (PHI) formulary on what is commonly used for treating their patient population and may or may not be available for patients not under the care of that institution. It does not reflect the PHI’s actual inventory availability and is subjected to change. Please consult the Public Hospitals or Polyclinics for details on availability and supply restrictions/considerations. General availability is not tied to any brand unless otherwise stated.
Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration
Availability information
Formulation | Public Healthcare Institution |
|---|---|
Extended-Release Oral Suspension 2 g |
|
Injection 500 mg |
|
Oral Suspension 200 mg/5 mL |
|
Tablet 250 mg |
|
Registered Product(s) Information
Clinical and product info
Clinical info | Product Info |
|---|---|
Information under the Indication, Dosage and Contraindication sections are extracted from the relevant Package Insert/Patient Information Leaflet of the product available on HSA Infosearch. For more information, please refer to the product's Package Insert/ Patient Information Leaflet available on HSA Infosearch. The information provided is for informational purposes only, and is not exhaustive. The information provided is not a substitute for professional medical advice. Please consult a qualified healthcare provider for any medical advice. | Information available here are product details as registered with the HSA. As this website is updated monthly, please refer to HSA Infosearch for the most updated product information. |
Oral
AZITHROMYCIN KERN PHARMA 200MG/5ML POWDER FOR ORAL SUSPENSION [SIN13977P]
AZITHROMYCIN KERN PHARMA 500MG FILM-COATED TABLETS [SIN13976P]
LESVI LAB AZITHROMYCIN FILM-COATED TABLETS 500MG [SIN14142P]*
LESVI LAB AZITHROMYCIN POWDER FOR ORAL SUSPENSION 200MG/5ML [SIN14141P]*
ZITHROMAX POWDER FOR ORAL SUSPENSION 200 MG/5 ML [SIN07863P]*
* Clinical information is available for this product.
Intravenous
AZITHROMYCIN MEVON POWDER FOR SOLUTION FOR INFUSION 500 MG/VIAL [SIN14490P]
AZITHROMYCIN-AFT POWDER FOR SOLUTION FOR INFUSION 500MG/VIAL [SIN16605P]*
ZITHROMAX IV POWDER FOR SOLUTION FOR INFUSION 500 MG/VIAL [SIN12057P]*
ZITHROTEL POWDER FOR SOLUTION FOR INFUSION 500MG/VIAL [SIN16876P]*
* Clinical information is available for this product.
